Basal Cell Carcinoma is the Most Common Type of Skin Cancer
Basal cell carcinoma (BCC) is definitively the most common type of skin cancer, followed by squamous cell carcinoma (SCC), with melanoma representing only about 1% of all skin cancers. 1
Understanding the Hierarchy of Skin Cancer Types
The evidence from the 2023 USPSTF guidelines clearly establishes the epidemiologic hierarchy:
- Basal cell carcinoma: Most common across all racial and ethnic groups 2, 3
- Squamous cell carcinoma: Second most common, accounting for approximately 20% of all skin cancers 4
- Melanoma: Represents only 1% of skin cancers but causes the most deaths 1
Together, BCC and SCC are classified as keratinocyte carcinomas (previously called non-melanoma skin cancers), and these collectively represent the vast majority of skin cancer diagnoses 1.
Clinical Significance Despite High Incidence
A critical caveat: While BCC is the most common, it infrequently leads to death or substantial morbidity 1. This is because BCC is typically slow-growing and highly curable 2, 3. In contrast, melanoma—though representing only 1% of cases—causes an estimated 8,000 deaths annually in the US and has dramatically different survival rates depending on stage (99.5% for localized disease versus 31.9% for distant-stage disease) 1.
Important Epidemiologic Considerations
BCC is so common that it's not even monitored by cancer registries, making reliable epidemiologic data difficult to obtain 1. This paradoxically means the most common cancer in the United States lacks comprehensive tracking systems because of its generally favorable prognosis.
The incidence varies by:
- Geography: Highest rates in Australia and New Zealand, followed by North America and Europe 5
- Race: More common in White persons, though persons with darker skin are often diagnosed at later stages 1
- UV exposure: Primary environmental risk factor across all types 2
Clinical Presentation to Watch For
BCC typically presents as a shiny, pink papule or nodule with telangiectasias on sun-exposed skin 3. However, presentation varies by histological subtype, requiring biopsy confirmation for definitive diagnosis.